CME Credit Hours: 1.25
Introduction
Sandy Kavalukas, MD, Louisville, KY
Alicia Logue, MD, San Antonio, TX
GS1 ASCL1: A Candidate Epigentically-Regulated Tumor Suppressor in HPV-Associated Malignancies
L. Hendrick*1, A. Elahi1, D. Wong1, A. Ajidahun1, M. Husain1, J. Lomax1, I. Getun1, R. Kansal1, E.S. Glazer1, D. Shibata1; 1Memphis, TN
Discussant: Grace Lee, MD, Boston, MA
GS2 Venous Thromboembolism Rates in Colorectal Cancer Patients Before and After Extended Prophylaxis Guidelines
A. Ore*1, P. Raje1, A. Fabrizio1, T.E. Cataldo1, K.T. Crowell1, E. Messaris1; 1Boston, MA
Discussant: Kent Peterson, MD, Milwaukee, WI
GS3 Multiple High-Risk Features in Stage II Colon Carcinoma Portend Worse Survival Than Stage III Disease
B.C. Herritt*1, C. Castellucci1, L. Hajirawala1, Y. Yi1, A. Klinger1, G.R. Orangio1, K. Davis1, J.S. Barton1; 1New Orleans, LA
Discussant: Paul McClelland, MD, Brooklyn, NY
GS4 Adjuvant Treatment and Survival in Patients with Stage II/III Small Bowel Adenocarcinoma
B. Li*1, E.C. Brown1, F. Egawa1, J. Lambrecht1, D.M. Krishnamurty1; 1Omaha, NE
Discussant: Sarah Morgan Kling, MD, Philadelphia, PA
GS5 Risk Factors for Microscopic Disease Positivity at Ileocolic Resection Margins for Crohn’s Disease
A. Truong*1, J. Chough1, K. Zaghiyan1, P. Fleshner1; 1Los Angeles, CA
Discussant: Ashlyn Whitlock, MD, Boston, MA
GS6 Colorectal Surgery ERAS: Lessons Learned Years Later
A.M. Madiedo*1, G. Rasic1, U.R. Phatak1, J.F. Hall1, J. Favuzza1; 1Allston, MA
Discussant: Scott Nguyen, MD, Honolulu, HI
GS7 The Association Between Sex and Survival for HPV Positive Anal Squamous Cell Carcinoma
V.M. Welten*1, A.C. Fields1, R.A. Malizia1, J. Yoo1, J. Irani1, R. Bleday1, J. Goldberg1, N. Melnitchouk1; 1Boston, MA
Discussant: Dalun Tang, MD, Ann Arbor, MI
GS8 Mediating Factors Between Patient Race and Time to Colorectal Cancer Treatment
M.W. Grunvald*1, J.M. Underhill1, C.T. Aquina1, A.R. Bhama1, D.M. Hayden1, A. Becerra1; 1Chicago, IL
Discussant: Stevie-Jay Stapler, MD, Ann Arbor, MI
Adjourn